Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Mayo Clinic Researchers Identify Role of Cul4 Molecule in Genome Instability and Cancer

Published: Monday, November 11, 2013
Last Updated: Monday, November 11, 2013
Bookmark and Share
Cul4 helps to deposit DNA-packaging histone proteins onto DNA, an integral step to help compact the genetic code.

When DNA isn't packaged correctly, it can lead to the genomic instability characteristic of many forms of cancer. The research is published in the Nov. 7 issue of the journal Cell. The results explain on a molecular level how Cul4 enables the handoff of histones from the proteins escorting them from their birthplace in the cell to their workplace on the DNA, where they can begin wrapping DNA up into tidy units called nucleosomes.

"We suggest that cancer cells may have evolved a mechanism to disrupt proper nucleosome assembly by altering Cul4 and other factors, which in turn could affect the stability of the genome and promote the formation of tumors," says senior study author Zhiguo Zhang, Ph.D., a molecular biologist at Mayo Clinic.

To protect the integrity of the genome, DNA is packaged tightly, first around spools of histone to form nucleosomes, then stacked on top of each other to form chromatin and finally looped and coiled to form chromosomes. Depending on whether and how histones interact with a given genetic sequence, the DNA is either closed up tightly within this package or lies open so that the underlying genes can be read and become active.

Researchers have long known that special proteins — called histone chaperones — escort histones around the cell, but how they finally let go of the histones to deposit them onto DNA was unclear.

Dr. Zhang wondered if Cul4, which is altered in a number of human cancers, including breast cancer, squamous cell carcinomas, adrenocortical carcinomas, and malignant mesotheliomas, might be involved. So he and his colleagues developed a series of cellular assays in yeast and in human cells to investigate the role of Cul4 in nucleosome assembly.

They found that Cul4 modifies the chemical entities on the surface of the histones, weakening the interaction between them and the histone chaperones charged with their care. They noticed that the same observations held true in the yeast indicating that the role of Cul4 in nucleosome assembly and genome stability is likely conserved between yeast and human cells.

"We uncovered a novel molecular mechanism whereby Cul4 regulates nucleosome assembly," says Dr. Zhang. "Our finding underscores the fact that proper regulation of the nucleosome assembly pathway is a key step in maintaining genome stability and epigenetic information."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Mayo, Baylor Collaborate
They aim to study genomic links to drug metabolism and other interactions which could be used to provide more tailored patient care.
Friday, May 15, 2015
First Steps in Formation of Pancreatic Cancer Identified
Researchers at Mayo Clinic’s campus in Jacksonville say they have identified first steps in the origin of pancreatic cancer and that their findings suggest preventive strategies to explore.
Tuesday, November 11, 2014
Mayo Clinic, UMMC Expand Relationship
Mayo Clinic and the University of Mississippi Medical Center have signed an agreement to broaden and deepen their collaboration in clinical trials, other medical research and education.
Monday, October 06, 2014
Mayo Clinic, Whole Biome Announce Collaboration
Joint development of microbiome diagnostic testing to focus on women’s health and preterm labor.
Tuesday, May 20, 2014
Virotherapy Shows Promise Against Multiple Myeloma
A Mayo Clinic proof of principle clinical trial, demonstrated that virotherapy, destroying cancer with a virus that infects and kills cancer cells but spares normal tissues, can be effective against multiple myeloma.
Friday, May 16, 2014
Mayo Clinic Launches Biobank in Arizona, Expanding Diversity Research
Mayo Clinic biobank will support studies in obesity, metabolism and diabetes, all areas of special concern in the Latino population.
Tuesday, October 15, 2013
Mayo Florida Receives $5M for Individualized Medicine Clinic
The donation from Florida residents Cecilia and Dan Carmichael will accelerate translation of research to patient care.
Wednesday, August 21, 2013
Mayo Clinic Forms Joint Venture with Cancer Genetics
OncoSpire Genomics will seek to discover and commercialize biomarkers for multiple cancer types.
Thursday, May 23, 2013
Why Does Smallpox Vaccine Shield Some, Not Others? It's in the Genes
How well people are protected by the smallpox vaccine depends on more than the quality of the vaccination: individual genes can alter their response, Mayo Clinic research shows.
Tuesday, April 23, 2013
Saliva Gland Test for Parkinson's Shows Promise
Findings described as a "big step forward" for research and treatment of Parkinson's disease.
Wednesday, January 16, 2013
Mayo Clinic Receives Funding for Gut Function Biomarker Research
The program aims to identify and validate biomarkers that can assess gut function and guide new ways to improve the health and development of children in the developing world.
Friday, December 28, 2012
Men with Fibromyalgia Often Go Undiagnosed, Mayo Clinic Study Suggests
There is not yet a diagnostic test to establish that someone has fibromyalgia, there is no cure and many symptoms can overlap with or get mistaken for other conditions.
Friday, December 21, 2012
Mitochondrial Dysfunction Present Early in Alzheimer’s, Before Memory Loss
Using genetic mouse models, Mayo Clinic researchers have discovered that mitochondria in the brain are dysfunctional early in the disease.
Thursday, March 01, 2012
Use of Over-the-Counter Thyroid Support Pills is Risky
Details of the study were presented at the annual meeting of the American Thyroid Association.
Tuesday, November 08, 2011
Mayo Clinic to Collaborate with Indian Science Leaders
The collaboration will cover areas such as drug, device and biomarker studies relating to heart disease, chemical biology, applied genomics and innovations in metabolomics.
Wednesday, October 19, 2011
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!